证券代码：300412 证券简称：迦南科技 公告编号：2025-038 浙江迦南科技股份有限公司 第六届监事会第八次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 浙江迦南科技股份有限公司（以下简称"公司"）第六届监事会第八次会议 通知于 2025 年 8 月 11 日以通讯方式送达全体监事 （1）会议时间：2025 年 8 月 21 日下午 （2）召开地点：公司会议室 （3）召开方式：以现场方式召开 （4）主持人：监事会主席王虎根先生 （5）监事出席会议情况：应出席监事 3 人，实际出席监事 3 人 具体内容详见同日披露在巨潮资讯网的《关于取消监事会暨修订 <公司章程> 的公告》。 表决结果：3 票同意、0 票反对、0 票弃权。 表决结果：3 票同意、0 票反对、0 票弃权。 案》 经审核，监事会认为：该专项报告客观、真实、准确、完整反映了公司募集 资金存放、使用、管理情况，公司募集资金存放、使用、管理符合中国证监会、 深圳证券交易所关于上市公司募集资金存放和使用的最新相关规定，不存在募集 资金存放和使用违规的情形。 具 ...

证券代码：300412 证券简称：迦南科技 公告编号：2025-041 浙江迦南科技股份有限公司 关于召开 2025 年第一次临时股东大会的通知 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 浙江迦南科技股份有限公司(以下简称"公司")第六届董事会第八次会议决 定于 2025 年 9 月 11 日（周四）下午 13:30 召开公司 2025 年第一次临时股东大 会，现将有关事项通知如下： 一、召开会议的基本情况 行政法规、部门规章、规范性文件和《公司章程》的规定。 （1）现场会议召开时间：2025 年 9 月 11 日（周四）下午 13:30； （2）通过深圳证券交易所交易系统进行网络投票的时间为 2025 年 9 月 11 日 9:15—9:25，9:30—11:30 和 13:00—15:00； （3）通过深圳证券交易所互联网系统投票的具体时间为 2025 年 9 月 11 日 备注 （1）现场投票：股东本人出席现场会议或通过填写授权委托书授权他人出 席现场会议。 （2）网络投票：公司将通过深圳证券交易所交易系统和互联网投票系统（http： //wltp ...

（文章来源：证券日报） 证券日报网讯 8月22日晚间，迦南科技发布公告称，2025年半年度公司实现营业收入559，772，249.70 元，同比增长1.29%；归属于上市公司股东的净利润为7，349，175.14元，同比下降38.46%。 ...

Group 1 - The company Canaan Technology announced that its sixth board of directors held its eighth meeting on August 22, where several proposals were approved, including the proposal for the 2025 semi-annual report and its summary [2]

（文章来源：证券日报） 证券日报网讯 8月22日晚间，迦南科技发布公告称，公司第六届监事会第八次会议审议通过了《关于 2025年半年度报告及其摘要的议案》等多项议案。 ...

证券日报网讯8月22日晚间，迦南科技（300412）发布公告称，公司于2025年8月21日召开职工代表大会 会议，会议选举周真道先生为公司第六届董事会职工代表董事。 ...

Group 1 - Gujia Home achieved a net profit of 1.02 billion yuan in the first half of 2025, a year-on-year increase of 13.89% [1] - Gujia Home's revenue for the first half of 2025 was 9.80 billion yuan, up 10.02% year-on-year [1] - Phoenix Holdings reported a net profit of 11.04 million yuan, successfully turning a profit [1] - Phoenix Holdings' revenue increased by 200.78% year-on-year to 291 million yuan [1] - Zheshang Securities recorded a net profit of 1.15 billion yuan, a year-on-year growth of 46.49% [1] - Zheshang Securities' revenue decreased by 23.66% to 6.11 billion yuan [1] Group 2 - Tianjin Port's net profit was 503 million yuan, a year-on-year decrease of 18.33% [3] - Tianjin Port's revenue for the first half of 2025 was 6.18 billion yuan, an increase of 4.33% year-on-year [3] - Xuantai Pharmaceutical reported a net profit of 45.59 million yuan, down 15.82% year-on-year [5] - Xuantai Pharmaceutical's revenue was 220 million yuan, a slight increase of 0.74% year-on-year [5] Group 3 - Yilida achieved a net profit of 40.03 million yuan, a year-on-year increase of 18.32% [7] - Yilida's revenue for the first half of 2025 was 758 million yuan, up 12.56% year-on-year [7] - Zhongji United reported a net profit of 262 million yuan, a significant year-on-year increase of 86.61% [9] - Zhongji United's revenue was 818 million yuan, a year-on-year growth of 43.52% [9] Group 4 - China Shipbuilding Special Gas reported a net profit of 178 million yuan, a slight decrease of 0.55% year-on-year [10] - China Shipbuilding Special Gas' revenue was 1.04 billion yuan, an increase of 12.60% year-on-year [10] - Xinyuan Intelligent Manufacturing achieved a net profit of 9.79 million yuan, a year-on-year increase of 284.45% [11] - Xinyuan Intelligent Manufacturing's revenue was 329 million yuan, up 388.33% year-on-year [11] Group 5 - Jiudian Pharmaceutical reported a net profit of 291 million yuan, a year-on-year increase of 2.57% [13] - Jiudian Pharmaceutical's revenue was 1.51 billion yuan, a year-on-year growth of 10.67% [13] - Boya Biological reported a net profit of 225 million yuan, down 28.68% year-on-year [15] - Boya Biological's revenue was 1.01 billion yuan, an increase of 12.51% year-on-year [15] Group 6 - True Love Home achieved a net profit of 197 million yuan, a year-on-year increase of 484.48% [17] - True Love Home's revenue was 390 million yuan, up 21.82% year-on-year [17] - Dongfang Electronics reported a net profit of 302 million yuan, a year-on-year increase of 19.65% [19] - Dongfang Electronics' revenue was 3.16 billion yuan, a year-on-year growth of 12.18% [19] Group 7 - Watte Holdings achieved a net profit of 18.41 million yuan, a year-on-year increase of 23.94% [21] - Watte Holdings' revenue was 906 million yuan, up 12.29% year-on-year [21] - Tianqin Equipment reported a net profit of 16.36 million yuan, a year-on-year increase of 2.78% [22] - Tianqin Equipment's revenue was 111 million yuan, a year-on-year growth of 18.42% [22] Group 8 - Yingfeng Environment achieved a net profit of 382 million yuan, a year-on-year increase of 0.43% [24] - Yingfeng Environment's revenue was 6.46 billion yuan, up 3.69% year-on-year [24] - Kexin Machinery reported a net profit of 52.20 million yuan, a year-on-year decrease of 46.18% [26] - Kexin Machinery's revenue was 592 million yuan, down 17.26% year-on-year [26] Group 9 - Tengda Construction reported a net profit of 108 million yuan, a year-on-year decrease of 0.69% [27] - Tengda Construction's revenue was 1.61 billion yuan, down 5.20% year-on-year [27] - Canaan Technology achieved a net profit of 7.35 million yuan, a year-on-year decrease of 38.46% [29] - Canaan Technology's revenue was 560 million yuan, up 1.29% year-on-year [29] Group 10 - Metro Design reported a net profit of 221 million yuan, a year-on-year increase of 6.58% [30] - Metro Design's revenue was 1.32 billion yuan, up 5.31% year-on-year [30] - China Shipbuilding Special Gas plans to use up to 2.9 billion yuan of idle funds for cash management [31] - The company intends to invest in safe, liquid, principal-protected products [31] Group 11 - Jiuchuang Biotechnology received a medical device registration certificate for its lupus anticoagulant detection kit [32] - The product is intended for in vitro qualitative detection of lupus anticoagulant in human plasma [32] - Xinowei's subsidiary received approval for clinical trials of its innovative drug [33] - The drug is a humanized monoclonal antibody intended for treating multiple cancers [33] Group 12 - Dongcheng Pharmaceutical's subsidiary received FDA approval for clinical trials of its targeted radiopharmaceutical [34] - The drug is intended for treating advanced prostate cancer [34] - Shandong Road and Bridge received approval to issue bonds up to 4 billion yuan [35] - The company specializes in road and bridge engineering construction [35] Group 13 - Diou Home plans to invest 500 million yuan to establish a subsidiary focused on generative AI [36] - The investment aims to transform the company into a full-stack industrial intelligent service provider [36] - Dayilong achieved a net profit of 90.87 million yuan, a year-on-year increase of 217.89% [37] - Dayilong's revenue was 957 million yuan, up 57.35% year-on-year [37] Group 14 - Chaohongji reported a net profit of 331 million yuan, a year-on-year increase of 44.34% [38] - Chaohongji's revenue was 4.10 billion yuan, up 19.54% year-on-year [38] - Taiji Group reported a net profit of 139 million yuan, a year-on-year decrease of 71.94% [39] - Taiji Group's revenue was 5.66 billion yuan, down 27.63% year-on-year [39] Group 15 - Suneng Co. reported a net profit of 93.19 million yuan, a year-on-year decrease of 90.13% [41] - Suneng Co.'s revenue was 5.57 billion yuan, down 17.15% year-on-year [41] - Three Gorges Water Conservancy reported a net profit of 47.93 million yuan, a year-on-year decrease of 79.07% [42] - Three Gorges Water Conservancy's revenue was 4.90 billion yuan, down 6.10% year-on-year [42] Group 16 - Furida reported a net profit of 108 million yuan, a year-on-year decrease of 15.16% [44] - Furida's revenue was 1.79 billion yuan, down 7.05% year-on-year [44] - Chenzhou Electric International achieved a net profit of 25.92 million yuan, a year-on-year increase of 29.55% [46] - Chenzhou Electric International's revenue was 1.96 billion yuan, up 1.26% year-on-year [46] Group 17 - Farlantek achieved a net profit of 122 million yuan, a year-on-year increase of 41.05% [47] - Farlantek's revenue was 1.18 billion yuan, up 46.63% year-on-year [47] - Huitai Medical reported a net profit of 425 million yuan, a year-on-year increase of 24.11% [48] - Huitai Medical's revenue was 1.21 billion yuan, up 21.26% year-on-year [48] Group 18 - Dameng Data's director is under investigation for suspected violations [49] - The company's daily operations remain normal [49] - Maiwei Co. reported a net profit of 394 million yuan, a year-on-year decrease of 14.59% [50] - Maiwei Co.'s revenue was 4.21 billion yuan, down 13.48% year-on-year [50] Group 19 - Waiservice Holdings achieved a net profit of 384 million yuan, a year-on-year increase of 5.51% [52] - Waiservice Holdings' revenue was 12.25 billion yuan, up 16.15% year-on-year [52] - Huakang Co. reported a net profit of 134 million yuan, a year-on-year decrease of 3.38% [53] - Huakang Co.'s revenue was 1.87 billion yuan, up 37.32% year-on-year [53] Group 20 - Bluelight Optical achieved a net profit of 103 million yuan, a year-on-year increase of 110.27% [54] - Bluelight Optical's revenue was 577 million yuan, up 52.54% year-on-year [54] - Shunwang Technology reported a net profit of 162 million yuan, a year-on-year increase of 69.22% [55] - Shunwang Technology's revenue was 1.01 billion yuan, up 25.09% year-on-year [55] Group 21 - Anbiping reported a net loss of 12.50 million yuan in the first half of 2025 [56] - Anbiping's revenue was 159 million yuan, down 30.11% year-on-year [56] - Jinhua Co. reported a net profit of 6.20 million yuan, a year-on-year decrease of 34.53% [57] - Jinhua Co.'s revenue was 241 million yuan, down 1.90% year-on-year [57] Group 22 - Xiehe Electronics achieved a net profit of 28.96 million yuan, a year-on-year decrease of 8.31% [59] - Xiehe Electronics' revenue was 451 million yuan, up 12.13% year-on-year [59] - Huguang Co. reported a net profit of 276 million yuan, a year-on-year increase of 8.40% [60] - Huguang Co.'s revenue was 3.63 billion yuan, up 6.20% year-on-year [60]

Group 1 - Company Canaan Technology announced on August 22 that it will reverse impairment provisions totaling approximately 4.96 million yuan for the first half of 2025 [2] - The amount of impairment provisions reversed is based on preliminary calculations by the company's finance department and has not been audited by an accounting firm [2] - Investors are advised to be cautious regarding investment risks associated with this announcement [2]

Core Viewpoint - Canaan Technology (300412.SZ) reported its 2025 semi-annual results, showing modest revenue growth but significant declines in net profit and adjusted net profit [1] Financial Performance - The company achieved operating revenue of 560 million yuan in the first half of the year, representing a year-on-year increase of 1.29% [1] - The net profit attributable to shareholders of the listed company was 7.3492 million yuan, a year-on-year decrease of 38.46% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 180,700 yuan, reflecting a year-on-year decline of 98.27% [1] - Basic earnings per share stood at 0.01 yuan [1]

Group 1 - The company Canaan Technology announced on August 22 that its sixth board meeting for the year 2025 was held via communication on August 20, 2025 [2] - The meeting reviewed the special report on the use and storage of raised funds for the first half of 2025 [2]